Odefsey and Dyspnea exacerbated - a phase IV clinical study of FDA data

Summary:

Dyspnea exacerbated is reported as a side effect among people who take Odefsey (emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarate), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Prezista, and have Dyslipidaemia.

The phase IV clinical study analyzes which people have Dyspnea exacerbated when taking Odefsey. It is created by eHealthMe based on reports of 4,585 people who have side effects when taking Odefsey from the FDA, and is updated regularly.

What is Odefsey?

Odefsey has active ingredients of emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 4,605 Odefsey users. Check the latest studies of Odefsey.

What is Dyspnea exacerbated?

Dyspnea exacerbated is found to be associated with 3,310 drugs and 1,659 conditions by eHealthMe. Check the latest studies of Dyspnea exacerbated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

4,585 people reported to have side effects when taking Odefsey.
Among them, 31 people (0.68%) have Dyspnea exacerbated.

Could Odefsey cause Dyspnea exacerbated?

Among these 31 people:

How long have people been on Odefsey when they have Dyspnea exacerbated? *

What is the gender of people who have Dyspnea exacerbated when taking Odefsey? *

female: 26.67 %
male: 73.33 %

What is the age of people who have Dyspnea exacerbated when taking Odefsey? *

What are other drugs people take besides Odefsey? *

Prezista: 9 people, 29.03%
Pepcid: 8 people, 25.81%
Tivicay: 8 people, 25.81%
Cardizem Cd: 7 people, 22.58%
Aspirin: 6 people, 19.35%
Pantoprazole: 5 people, 16.13%
Ritonavir: 4 people, 12.90%
Gabapentin: 4 people, 12.90%
Pregabalin: 4 people, 12.90%
Venlafaxine Hydrochloride: 4 people, 12.90%

What are other side effects people have besides Dyspnea exacerbated? *

Abdominal Pain: 8 people, 25.81%
Confusional State: 8 people, 25.81%
Blood Creatine Phosphokinase Increased: 8 people, 25.81%
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 8 people, 25.81%
Stress And Anxiety: 6 people, 19.35%
Weakness: 5 people, 16.13%
Fatigue (feeling of tiredness): 4 people, 12.90%
Arrhythmias (irregular heartbeat): 4 people, 12.90%
Dizziness: 4 people, 12.90%
Emotional Distress: 3 people, 9.68%

What are the existing conditions these people have? *

Dyslipidaemia (abnormal amount of lipids): 8 people, 25.81%
Depression: 2 people, 6.45%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 3.23%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 3.23%
Neuropathy Peripheral (surface nerve damage): 1 person, 3.23%
High Blood Cholesterol: 1 person, 3.23%
Hepatitis B: 1 person, 3.23%
Diabetes: 1 person, 3.23%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 3.23%
Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Odefsey and have Dyspnea exacerbated?

- Check whether Dyspnea exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Odefsey:

Odefsey (4,605 reports)

Dyspnea exacerbated treatments and more:

Dyspnea exacerbated (2,061 reports)

How severe was Dyspnea exacerbated and when was it recovered:

Dyspnea exacerbated in Odefsey

Expand to all the drugs that have ingredients of emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarate:

Dyspnea exacerbated and drugs with ingredients of emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Odefsey:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (3,310 drugs)

Browse all the conditions that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (1,659 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarate (the active ingredients of Odefsey) and Odefsey (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.